Raymond James Upgrades Amyris, Inc. (AMRS) to Market Perform
Tweet Send to a FriendGet Alerts AMRS Hot Sheet
Price: $3.03 +2.36%
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 36 | New: 12
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 36 | New: 12
Trade AMRS Now!
Raymond James upgraded Amyris, Inc. (NASDAQ: AMRS) from Underperform to Market Perform on better entry points.
"We are reversing our tactical downgrade from February 12, returning the rating to Market Perform," analyst Pavel Molchanov said. "The market was clearly not enthused about Amyris' 4Q12 results, sending the stock down 7% yesterday. Combined with weakness ahead of the results, the multiple has come down to 95% of DCF - a level that, while still the highest among peers, no longer warrants an Underperform rating, in our view."
For an analyst ratings summary and ratings history on Amyris, Inc. click here. For more ratings news on Amyris, Inc. click here.
Shares of Amyris, Inc. closed at $3.17 yesterday, with a 52 week range of $1.57-$6.69.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"We are reversing our tactical downgrade from February 12, returning the rating to Market Perform," analyst Pavel Molchanov said. "The market was clearly not enthused about Amyris' 4Q12 results, sending the stock down 7% yesterday. Combined with weakness ahead of the results, the multiple has come down to 95% of DCF - a level that, while still the highest among peers, no longer warrants an Underperform rating, in our view."
For an analyst ratings summary and ratings history on Amyris, Inc. click here. For more ratings news on Amyris, Inc. click here.
Shares of Amyris, Inc. closed at $3.17 yesterday, with a 52 week range of $1.57-$6.69.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- The Law Firm of Wohl & Fruchter Has Filed a Complaint Against Amyris, Inc.
Create E-mail Alert Related Categories
UpgradesRelated Entities
Raymond James
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
